Transparency Initiative Will Give Updates on Guidance Process

A A
Industry may see an end to indefinite waits for major guidances as the FDA could develop timelines for producing the documents.

To View This Article:

Login

Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $40.00